Results 201 to 210 of about 363,419 (348)
Toll-like receptor 2 deficiency exacerbates corneal angiogenesis in injury by impairing regulatory T cells. [PDF]
Ko JH +9 more
europepmc +1 more source
Toll-like Receptor 2 Mediated Immune Regulation in Simian Immunodeficiency Virus-Infected Rhesus Macaques. [PDF]
Boby N, Williams KM, Das A, Pahar B.
europepmc +1 more source
Abstract Federal funding pauses, once considered rare, are increasingly disrupting the stability and continuity of community‐engaged research. Even projects with active, awarded grants are experiencing the strain of funding uncertainty, raising substantive concerns among research teams and community partners. These disruptions extend beyond operational
Brynn E. Sheehan
wiley +1 more source
Toll-like receptor 2 activation of early divided bovine embryo promotes its viability and development competence in vitro. [PDF]
Ma D +7 more
europepmc +1 more source
Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer? [PDF]
Majewski M +7 more
europepmc +1 more source
TOLL-LIKE RECEPTOR 2, 4 AND 9 GENETIC VARIANTS IN MEXICAN PATIENTS WITH AMOEBIC LIVER ABSCESS
Oswaldo Partida‐Rodríguez +14 more
openalex +1 more source
Integrin activation by bacterial fimbriae through a pathway involving CD14, Toll‐like receptor 2, and phosphatidylinositol‐3‐kinase [PDF]
Evlambia Harokopakis +1 more
openalex +1 more source
ABSTRACT Sickle cell disease (SCD) is a chronic inflammatory state, characterized by increased plasma values of inflammatory and angiogenic proteins. Although red blood cell (RBC) transfusion is known to have immunomodulatory effects in other conditions, its potential effects on the inflammatory state in SCD remain largely unknown.
Lydian A. de Ligt +9 more
wiley +1 more source

